Design Therapeutics, Inc. (DSGN) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $16.86M | -25.3% |
| 2024 | $22.56M | +6.4% |
| 2023 | $21.20M | -20.0% |
| 2022 | $26.50M | -91.1% |
| 2021 | $298.57M | +12450.2% |
| 2020 | $2.38M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $16.86M | -25.3% |
| 2024 | $22.56M | +6.4% |
| 2023 | $21.20M | -20.0% |
| 2022 | $26.50M | -91.1% |
| 2021 | $298.57M | +12450.2% |
| 2020 | $2.38M | — |